Home
Pluristem Therapeutics, Inc.

Pluristem Therapeutics, ... Market Share Analysis for June 2026

ABOUT Since 2003, Pluri has perfected methods to consistently expand a single placenta cell into billions of distinct cells. The cell expansion process drives the development of groundbreaking cell-based therapies targeting a variety of medical indications. These therapies are ushering in a new era of more targeted, personalized, and well-tolerated treatments. Because Pluri’s placenta-derived, allogeneic […]

Science and Education > Biology

Domainpluristem.com

Year Founded2001

Employees51 - 200

Annual Revenue$1M - $2M

Pluristem Therapeutics, Inc.

Pluristem Therapeutics, Inc. (including company regionals)

pluristem.com

See more website traffic and engagement information

Pluristem Therapeutics, Inc. Revenue up to June 2026 is 1M - 2M

revenue generated by Pluristem Therapeutics, Inc. top domains

Pluristem Therapeutics, Inc. top domains revenue over 3 years

Revenue for Pluristem Therapeutics, Inc. top domains

pluristem.com1M - 2M

See more with Sales Intelligence

Total visits to Pluristem Therapeutics, Inc.'s top domains

Understand Pluristem Therapeutics, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Pluristem Therapeutics, Inc.'s top domains

Analyze Pluristem Therapeutics, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Pluristem Therapeutics, Inc.'s top domains

See how Pluristem Therapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Pluristem Therapeutics, Inc. top competitors by domain

Top similar sites in June 2026, ranked by their affinity

stemcellsinc.comCompany NameStemCells, Inc.Employees51 - 200HQUnited States, California, Palo AltoAnnual revenue$15M - $25MTotal visits--Science and Education > Biology

Top technologies used by Pluristem Therapeutics, Inc.

These are the website technologies, by industry, used by Pluristem Therapeutics, Inc. top domains

Advertising (7)

DoubleClick

Conversion & Analytics (5)

Google Analytics

Audio Video Media (4)

YouTube

Widget (4)

Twemoji

More Technologies

10

See all

News & Signals from Pluristem Therapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPluristem GmbH partnered with Hemafund on Mar 21st '25.To prepare for such an eventuality, last month, Haifa-based Pluri (formerly Pluristem) entered into an exclusive collaboration with Ukrainian umbilical cord blood bank Hemafund to stockpile and distribute its placental expanded cell therapy, PLX-R18, as a potential treatment for life-threatening radiation sickness, the Times of Israel reported.

NewsPluristem GmbH launched MAIT immunotherapy platform on May 1st '24.MAIT cells hold immense potential for immunotherapy and the treatment of solid tumors compared to conventional T-cells, but their expansion has been a challenge until Pluri announced its proprietary MAIT immunotherapy platform in May 2024